FDA’s medical review departments remain untouched (for now) by Musk’s cuts

Zachary Brennan

Senior Editor

Since President Donald Trump took office, Elon Musk’s Department of Government Efficiency has laid off thousands of government workers through broad, sudden cuts — some later …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA’s medical review departments remain untouched (for now) by Musk’s cuts

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

Ono licenses rare blood disease drug from Ionis for $280M upfront

Legend to double Carvykti production as it targets blockbuster status

Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’

Corrected: Merck opens billion-dollar US facility to make Gardasil

Obesity drug development—still room to grow

FDA’s med­ical re­view de­part­ments re­main un­touched (for now) by Musk’s cuts

Senior Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

FDA’s medical review departments remain untouched (for now) by Musk’s cuts